Tozorakimab (MEDI3506): a dual-pharmacology anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction https://www.biorxiv.org/content/10.1101/2023.02.28.527262v1?med=mas
Tozorakimab (MEDI3506): a dual-pharmacology anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction https://www.biorxiv.org/content/10.1101/2023.02.28.527262v1?med=mas